Ads
related to: crispr therapeutics
Search results
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Zacks via Yahoo Finance· 3 days agoRecently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 20 hours agoCRISPR Therapeutics (NASDAQ: CRSP) closed last week down 8.5% after reporting first-quarter...
CRISPR Therapeutics’ (CRSP) Neutral Rating Reiterated at Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoCantor Fitzgerald reissued their neutral rating on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research note issued to investors on Thursday ...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 5 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the ...
We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
Simply Wall St. via Yahoo Finance· 6 days agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo Finance· 7 days agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher
Simply Wall St. via Yahoo Finance· 5 days agoCRISPR Therapeutics AG (NASDAQ:CRSP) shareholders will have a reason to smile today, with the...
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
GuruFocus.com via Yahoo Finance· 6 days agoCollaboration Expense: Rose to $47.0 million, compared to $42.2 million in the first quarter of 2023. On May 8, 2024, CRISPR Therapeutics AG (NASDAQ:CRSP ...
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024
InvestorPlace· 32 minutes agoYou’d be sitting on 377% in gains if you invested in the overall market exactly 20 years back. The investing landscape right now may be better than many think, for those looking for buy-and-hold ...
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
InvestorPlace via Yahoo Finance· 6 days agoGenomics is the future of medicine. With it, companies are racing to shed light on human health and...